Are NSAIDs Safe? Assessing the Risk-Benefit Profile of Nonsteroidal Anti-inflammatory Drug Use in Postoperative Pain Management
Authors:
- 26 November 2020
- journal article
- research article
- Published by SAGE Publications in The American Surgeon™
- Vol. 87 (6) , 872-879
Abstract
In this article, we review controversies in assessing the risk of serious adverse effects caused by administration of nonsteroidal anti-inflammatory drugs (NSAIDs). Our focus is upon NSAIDs used in short courses for the management of acute postoperative pain. In our review of the literature, we found that the risks of short-term NSAID use may be overemphasized. Specifically, that the likelihood of renal dysfunction, bleeding, nonunion of bone, gastric complications, and finally, cardiac dysfunction do not appear to be significantly increased when NSAIDs are used appropriately after surgery. The importance of this finding is that in light of the opioid epidemic, it is crucial to be aware of alternative analgesic options that are safe for postoperative pain control.Keywords
This publication has 48 references indexed in Scilit:
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in miceProceedings of the National Academy of Sciences, 2012
- A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial of Intravenous Ibuprofen (IV‐Ibuprofen) in the Management of Postoperative Pain Following Abdominal HysterectomyPain Practice, 2011
- BMP‐7–induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6‐miceJournal of Orthopaedic Research, 2010
- A Randomized Controlled Trial Comparing Acetaminophen plus Ibuprofen Versus Acetaminophen plus Codeine plus Caffeine after Outpatient General SurgeryJournal of the American College of Surgeons, 2008
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Rofecoxib (Vioxx) voluntarily withdrawn from marketCanadian Medical Association Journal, 2004
- Postoperative naproxen after coronary artery bypass surgery: a double-blind randomized controlled trialEuropean Journal of Cardio-Thoracic Surgery, 2004
- Does ibuprofen increase perioperative blood loss during hip arthroplasty?European Journal of Anaesthesiology, 2002
- Mechanisms of Gastrointestinal Toxicity of Nonsteroidal Anti-Inflammatory DrugsScandinavian Journal of Gastroenterology, 1989